Maxion Therapeutics
PrivateLast Round
Series A
Mar 17, 2025
Total Funding Raised
$90.5M
Company Overview
Maxion Therapeutics is a biotechnology company that develops antibody-based KnotBody® drugs for ion channel and G protein-coupled receptor (GPCR)-driven diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Maxion Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Maxion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 17, 2025 | ||||
| Grant | Apr 19, 2023 | ||||
| Seed | Feb 15, 2023 |
Key People
Founding team and executive leadership
Maxion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| BGF | Series A, Seed |
| British Patient Capital | Series A |
| Monograph Capital | Series A, Seed |
| General Catalyst | Series A |
| Innovate UK | Grant |
| British Patient Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Joel Edwards appointed as new Chief Business Officer.
- Aug 27, 2025
Dr. Santiago Arroyo appointed as Non-Executive Director.
Maxion Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Maxion Therapeutics's valuation, stock price, and market status.